User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Safety and efficacy of Sofosbuvir/Velpatasvir for the treatment of chronic hepatitis C infection in adolescents and children aged 3 to 17 years old through 24 weeks post treatment

  • Open access
  • PDF
  • 261.80 K
  • Open access
  • PDF
  • 3.11 M
Bibliographic reference Sokal, Etienne ; et. al. Safety and efficacy of Sofosbuvir/Velpatasvir for the treatment of chronic hepatitis C infection in adolescents and children aged 3 to 17 years old through 24 weeks post treatment.The Liver Meeting Digital Experience - AASLD (WEBINAR, du 13/11/2020 au 16/11/2020). In: Journal of Hepatology. Supplement, Vol. 72, no.931, p. 570A (2020)
Permanent URL http://hdl.handle.net/2078.1/243438